Market closedNon-fractional

Aura Biosciences/AURA

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Aura Biosciences

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its lead candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Ticker

AURA

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Boston, United States

Employees

89

Aura Biosciences Metrics

BasicAdvanced
$342M
Market cap
-
P/E ratio
-$1.85
EPS
0.37
Beta
-
Dividend rate
$342M
0.37
21.965
20.995
7.941
9.254
-24.90%
-40.43%
1.62
1.62
-4.044
-6.44%
-71.03%

What the Analysts think about Aura Biosciences

Analyst Ratings

Majority rating from 6 analysts.
Buy

Aura Biosciences Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$20M
-10.86%
Profit margin
0.00%
NaN%

Aura Biosciences Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 17.73%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.48
-$0.48
-$0.56
-$0.40
-
Expected
-$0.49
-$0.52
-$0.41
-$0.49
-$0.45
Surprise
-1.96%
-7.83%
35.86%
-17.73%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Aura Biosciences stock?

Aura Biosciences (AURA) has a market cap of $342M as of July 06, 2024.

What is the P/E ratio for Aura Biosciences stock?

The price to earnings (P/E) ratio for Aura Biosciences (AURA) stock is 0 as of July 06, 2024.

Does Aura Biosciences stock pay dividends?

No, Aura Biosciences (AURA) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Aura Biosciences dividend payment date?

Aura Biosciences (AURA) stock does not pay dividends to its shareholders.

What is the beta indicator for Aura Biosciences?

Aura Biosciences (AURA) has a beta rating of 0.37. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Aura Biosciences stock

Buy or sell Aura Biosciences stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing